Catastrophic cerebral antiphospholipid syndrome presenting as cerebral infarction with haemorrhagic transformation after sudden withdrawal of warfarin in a patient with primary antiphospholipid syndrome

BMJ Case Reports

Volumn , Issue , 2010, Pages

  Wani, Abdul Majid ^a   Hussain, Waleed Mohd ^a   Al Mejally, Mousa Ali ^a   Ali, Khaled Shawkat ^a   Raja, Sadeya Hanif ^a   Al Maimani, Wael ^b   Bafaraj, Mazen G ^a   Bashraheel, Ashraf ^a   Akhtar, Mubeena ^a   Khoujah, Amer Mohd ^c  

^a HERA GENERAL HOSPITAL   (Saudi Arabia)

^b UMM AL QURA UNIVERSITY   (Saudi Arabia)

^c National Guard Hospital   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873887822     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr.09.2009.2243     Document Type: Article

References (12)

1. Modrykamien A, Reddy A, Guzman JA, et al. Massive cerebrovascular infarct due to the catastrophic antiphospholipid syndrome in a patient with idiopathic thrombocytopenic purpura. J Intensive Care Med 2009; 24: 269-72. [Abstract/FREE Full text]
2. Cervera R, Bucciarelli S, Plasín MA, et al. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry". J Autoimmun 2009; 32: 240-5. [CrossRef] [Medline] [Web of Science]
3. Ortega-Hernandez OD, Agmon-Levin N, Blank M, et al. The physiopathology of the catastrophic antiphospholipid (Asherson's) syndrome: compelling evidence. Autoimmun 2009; 32: 1-6. [CrossRef]
4. Espinosa G, Bucciarelli S, Asherson RA, et al. Morbidity and mortality in the catastrophic antiphospholipid syndrome: pathophysiology, causes of death, and prognostic factors. Semin Thromb Hemost 2008; 34: 290-4. [CrossRef] [Medline] [Web of Science]
5. Huang MN, Hsieh SC. Catastrophic antiphospholipid syndrome in the central nervous system. J Rheumatol 2009; 36: 651. [FREE Full text]
6. Coward LJ, Kullmann DM, Hirsch NP, et al. Catastrophic primary antiphospholipid syndrome presenting as status epilepticus. J Neurol Neurosurg Psychiatry 2005; 76: 1607-8. [FREE Full text] (Pubitemid 41531722)
7. Miabi Z, Midia R, Rohrer SE, et al. Delineation of lateral tentorial sinus with contrast-enhanced mr imaging and its surgical implications. Am J Neuroradiol 2004; 25: 1181-8. [Abstract/FREE Full text] (Pubitemid 39095165)
8. Asherson RA, Cervera R, de Groot PG. Catastrophic antiphospholipid syndrome: International consensus statement on classification criteria and treatment guidelines. Lupus 2003; 12: 530-4. [Abstract/FREE Full text] (Pubitemid 36890145)
9. Erkan D, Yazici Y, Peterson MG, et al. A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome. Rheumatology 2002; 41: 924-9. [Abstract/FREE Full text]
10. Asherson RA, Cervera R, Piette JC, et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) 1998; 77: 195-207. [CrossRef] [Medline] (Pubitemid 28290020)
11. Trappolini M, Scorzai A, Loguercio V, et al. Splenic infarction after warfarin discontinuation during atrial fibrillation. Clin Ter 2008; 159: 435-7. [Medline] [Web of Science]
12. Genewein U, Haeberli A, Straub PW, et al. Rebound after cessation of oral anticoagulant therapy: the biochemical evidence. Br J Haematol 1996; 92: 479-85. [CrossRef] [Medline] [Web of Science] (Pubitemid 26042945)